Cancun, Mexico. April 2013 Lectures Topics: Prostate Cancer Biomarkers and Active Surveillance Category: Prostate Cancer
Cancun, Mexico. April 2013 Lectures Topics: Prostate Cancer Biomarkers and Active Surveillance Category: Prostate Cancer
Loeb S. “Does Delaying Prostate Cancer Treatment Miss the Window of Curability?” European Urology 2013 epub Apr 8. PMID: 23619388 Link: http://www.ncbi.nlm.nih.gov/pubmed/23619388
Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ. “Personalized PSA Testing Using Genetic Variants May Reduce Unnecessary Biopsies.” Journal of Urology 2012; epub December. PMID: 23246478. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631301/ Correcting the PSA level for a man’s genotype could potentially reduce the number of men referred for prostate biopsy… Read More
Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crowe J, Clarke N, Cooperberg M, Gillatt D, Gleave M, Loeb S, Roobol M, Sartor O, Pickles T, Wooten A, Walsh PC, Costello AJ. “The Melbourne Consensus Statement on the Early Detection of Prostate Cancer.” British Journal of Urology International 2012 epub Nov 8. PMID: 24206066 Link:… Read More
Loeb S, Drevin L, Robinson D, Holmberg E, Carlsson S, Lambe M, Stattin P. “Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.” Cancer Causes Control 2012; December epub. PMID: 23266834. Link: http://www.ncbi.nlm.nih.gov/pubmed/23266834 First-generation immigrants to Sweden (a high risk country for prostate cancer) have a lower… Read More
6/2012 The Doctor’s Channel video on PSA Screening- Decision Making at the Individual Level http://www.thedoctorschannel.com/view/psa-screening-decision-making-at-the-individual-level/collection/prostatecancer/
Nickel JC, Partin AW, Nirmal J, Chancellor MB, Loeb S, Brawer MK, Assimos D, and Shapiro E. “Best of 2012 AUA Annual Meeting: Highlights from the 2012 American Urological Association Meeting, May 19-23, 2012, Atlanta, GA.” Reviews in Urology 2012; 14: 90-103. PMID: 23526762 Link: http://www.ncbi.nlm.nih.gov/pubmed/23526762
Loeb S. “Prostate Cancer Screening and Surgical Management of Localized Disease: Highlights from the 27th Annual Congress of the European Association of Urology, February 24-28, 2012, Paris, France.” Reviews in Urology 2012; 14: 87-9. PMID: 23526727 Link: http://www.ncbi.nlm.nih.gov/pubmed/23526727
Marberger M, Barentsz J, Emberton M, Hugosson J, Loeb S, Klotz L, Koch M, Shariat SF, Vickers A. “Novel approaches to improve prostate cancer diagnosis and management in early-stage disease.” BJU International 2012; 109 Suppl 2: 1-7. PMID: 22257098. Link: http://www.ncbi.nlm.nih.gov/pubmed/22257098
Loeb S and Borin JF. “Innovation in Endourology and Minimally Invasive Surgery. Highlights from the 29th World Congress of Endourology and SWL 2011, November 30-December 3, 2011, Kyoto, Japan.” Reviews in Urology 2012; 14: 28-30. PMID: 23172997. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502049/
Brawer MK, Loeb S, Partin AW, Nirmal J, Chancellor MB, Nickel JC, Rajfer J, Shapiro E, and Roehrborn CG. “Best of the AUA Annual Meeting: Highlights from the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC.” Reviews in Urology 2011; 13: 151-72. PMID: 22114546. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725309/
Melbourne, Australia. August 2012 Lecture Topics: Prostate biopsy complications, Overdiagnosis and Overtreatment of Prostate Cancer Category: Prostate Complications
Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. “Is repeat prostate biopsy association with a greater risk of hospitalization? Data from SEER-Medicare.” Journal of Urology epub Oct 9, 2012. PMID: 23063634. Link: http://www.ncbi.nlm.nih.gov/pubmed/23063634
Loeb S, Braithwaite RS, Hayes RB. “Utility of single nucleotide polymorphisms in prostate biopsy decisions.” Reviews in Urology 2012; 14: 115-7. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602735/
8/2012 Australasian Prostate Cancer Conference- Lecture on prostate cancer overdiagnosis and overtreatment
6/2012 The Doctor’s Channel video on Prostate Cancer Biopsy Guidelines and Procedures http://www.thedoctorschannel.com/view/prostate-cancer-biopsy-guidelines-and-procedures/collection/prostatecancer/
Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ. “Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial.” European Urology June 2012; 61: 1110-4. PMID: 22244150 Link: http://www.ncbi.nlm.nih.gov/pubmed/22244150 Among men undergoing prostate biopsy in the European Randomized Study of Screening for Prostate Cancer (ERSPC), 4% developed… Read More
León, Mexico, April 2012 Lectures Topic: Prostate Cancer Screening Category: Prostate Cancer
Mullins JK, Loeb S. “Environmental exposures and prostate cancer.” Urologic Oncology: Seminars and Investigations, March 2012; 30: 216. PMID: 22385992. Link: http://www.ncbi.nlm.nih.gov/pubmed/22385992
Loeb S, Metter EJ, Kan D, Roehl KA, Catalona WJ. “Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer.” BJU International. 2012 Feb;109(4):508-13. PMID: 22296334 Link: http://www.ncbi.nlm.nih.gov/pubmed/22296334 Sustained rises in PSA indicate a significantly greater risk of prostate cancer, particularly high-grade disease. Men with 2 successive PSA velocity… Read More
Loeb S, Carter HB, Catalona WJ, Moul JW, and Schroder FH. “Baseline Prostate-Specific Antigen Testing at a Young Age.” European Urology January 2012; 61: 1-7. PMID: 21862205. Link: http://www.ncbi.nlm.nih.gov/pubmed/21862205 This study reviews the published literature showing that baseline PSA measurements at a young age are significant predictors of later prostate cancer diagnosis and disease-specific outcomes…. Read More
Loeb S, Carter HB, Berndt SI, Ricker W, and Schaeffer EM. “Complications After Prostate Biopsy: Data From SEER-Medicare.” Journal of Urology November 2011; 186: 1830. PMID: 21926375. Link: http://www.ncbi.nlm.nih.gov/pubmed/21944136 This was the first paper to call attention to the increasing risk of hospitalization for infection after prostate biopsy in the United States. Careful patient selection… Read More
Loeb S. “Germline Sequence Variants and Prostate Specific Antigen Interpretation.” Clinical Chemistry May 2011; 57: 662-3. PMID: 21411622. Link: http://www.ncbi.nlm.nih.gov/pubmed/21411622
Catalona WJ, Partin AW, Sanda MG, Wei JT, Klee GG, Bangma CH, Slawin KM, Marks LS, Loeb S, Broyles DL, Shin SS, Cruz AB, Chan DW, Sokoll LJ, Roberts WL, van Schaik RH, Mizrahi IA. “A Multicenter Study of [-2] Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate… Read More
Summer 2011 Elizabeth Pickett Award The goal of this award is to perform summer research in the Netherlands with the European Randomized Study of Screening for Prostate Cancer.
Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, and Catalona WJ. “What is the true number-needed-to-screen and treat to save a life with prostate-specific antigen (PSA) testing?” Journal of Clinical Oncology January 2011; 29: 464. Link: http://www.ncbi.nlm.nih.gov/pubmed/21189374 Although number needed to screen (NNS) and number needed to treat (NNT) are useful statistics to… Read More
Mullins JK and Loeb S. “Diabetes Mellitus and Prostate Cancer Risk.” Expert Review of Endocrinology and Metabolism November 2010; 5: 787.
Loeb S, Carter HB, Schaeffer EM, Ling SM, Kettermann A, Ferrucci L, and Metter EJ. “Bone Mineral Content and Prostate Cancer Risk: Data from the Baltimore Longitudinal Study of Aging.” BJU International, July 2010; 106: 28. Link: http://www.ncbi.nlm.nih.gov/pubmed/20067459
Loeb S, Kan D, Helfand BT, Gashti SN, Nadler RB, and Catalona WJ. “Is Statin Use Associated with Prostate Cancer Aggressiveness?” BJU International 2009, Nov 3 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19888973
Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, and Walsh PC. “Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.” Journal of Clinical Oncology, June 2010; 28: 2810. Link: http://www.ncbi.nlm.nih.gov/pubmed/20439642 PSA doubling time and PSA velocity are frequently used… Read More
Loeb S, Helfand BT, Kan D, Isaacs WB, and Catalona WJ. “Does Diabetes Mellitus Modify the Association between 17q12 Risk Variant and Prostate Cancer Aggressiveness?” BJU International, November 2009; 104: 1200. Link: http://www.ncbi.nlm.nih.gov/pubmed/19627283
Loeb S, Schaeffer EM, Trock BJ, Humphreys EB, Epstein JI, and Walsh PC. “What are the Outcomes of Radical Prostatectomy for High-Risk Prostate Cancer?” Urology 2009, Nov 19 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19931898 Historically most men with D’Amico high-risk prostate cancer (clinical stage ≥T2c, biopsy Gleason score 8-10, or prostate-specific antigen >20 ng/mL) were treated with combined… Read More
Brawer MK, Loeb S, Partin AW, Yoshimura N, Chancellor MB, Roehrborn CG, Assimos DG, Nickel JC, Shuch B, Pouliot F, Belldegrun AS, and Shapiro E. “Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.” Reviews in Urology, Spring 2009; 11: 82.
Loeb S and Schaeffer EM. “Risk Factors, Prevention, and Early Detection of Prostate Cancer.” Primary Care Clinics of North America, September 2009; 36: 603. Link: http://www.ncbi.nlm.nih.gov/pubmed/19616157
Loeb S and Partin AW. “Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention.” Reviews in Urology, Spring 2009; 11: 114. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725311/
Trock BJ, Guo CC, Gonzalgo ML, Magheli A, Loeb S, and Epstein JI. “Impact of Tertiary Gleason Patterns on Biochemical Recurrence Following Radical Prostatectomy: Proposal for a Modified Gleason Scoring.” Journal of Urology, August 2009 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19683280
Loeb S, Epstein JI, Humphreys EB, and Walsh PC. “Does Perineural Invasion on Prostate Biopsy Predict Adverse Prostatectomy Outcomes?” BJU International, August 2009 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19694710
Loeb S, Carter HB, Walsh PC, Isaacs WB, Kettermann A, Tanaka T, Ferrucci L, and Metter EJ. “Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate-Specific Antigen Level.” Journal of Urology, July 2009; 182: 101. Link: http://www.ncbi.nlm.nih.gov/pubmed/19450841 Genotype influences the risk of prostate cancer per unit increase in PSA. Prostate cancer… Read More
Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, and Catalona WJ. “Pathological Outcomes Associated with the 17q Prostate Cancer Risk Variants.” Journal of Urology, June 2009; 181: 2502. Link: http://www.ncbi.nlm.nih.gov/pubmed/19371897
Schaeffer EM, Carter HB, Kettermann A, Loeb S, Ferrucci L, Landis P, Trock BJ, and Metter EJ. “Prostate Specific Antigen Testing Among the Elderly: When to Stop?” Journal of Urology, April 2009; 181: 1606. Link: http://www.ncbi.nlm.nih.gov/pubmed/19246059 Men ages 75-80 with PSA levels <3 ng/ml are unlikely to die of or experience aggressive prostate cancer during… Read More